CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Explore various ways to make money while working from home. Learn how to balance work and income generation effectively.
27,770 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Whale.io launches native world 2026 prediction markets, offering a total prize pool of $90,000 and a series of weekly...
SpaceX is exploring a historic mega-IPO with a razor-thin gross spread. Goldman leads a bid to win the deal at one of...
Investors face a pivotal choice in 2026: chase the next NVIDIA or buy the real thing. The AI stock rotation puts AMD ...
Private equity takes the helm at Pizza Hut in a $2.7 billion split deal, redefining a 1950s-era brand for the modern ...
A fresh OpenAI policy hire has warned that government monopoly over frontier AI testing could slow innovation and rai...
The White House signed two executive orders Friday to accelerate quantum research and shield federal data from future...
Rumors swirl about a $1B annual AI deal behind Siri’s next leap. This article breaks down who benefits, how it change...
In late June 2026, XRP and XLM are both testing breakout attempts after weeks of consolidation. Neither has confirmed...
Two blue-chip banks report divergent 2026 results: Morgan Stanley leans on wealth advisory, while JPMorgan runs a uni...
U.S. equities closed the second quarter with a double‑digit rally, led by AI-driven tech names. Yet analysts warn tha...
Robinhood launches its on-chain network, sparking a memecoin surge as traders rush into DeFi and tokenized assets. Th...